WithdrawnPhase 4

POSTERIOR SUB-TENON'S Avastin

Stopped: Poor accrual

Mexico0Started 2008-06

Plain-language summary

Posterior sub-tenon's injection of bevacizumab decreased diffuse diabetic macular edema

Who can participate

Age range25 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients with diffuse diabetic macular edema non-proliferative diabetic retinopathy Maculat thickness ≥250 μ BCVA ≥ 20/400 Without any treatment

What they're measuring

macular volume

Timeframe: baseline, 3,6 and 12 weeks

Trial details

NCT IDNCT00567372

SponsorAsociación para Evitar la Ceguera en México

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-11

View on ClinicalTrials.gov More Diffuse Diabetic Macular Edema trials